Mechanical circulatory support with microaxial flow pumps is now well established in routine practice for the management of cardiogenic shock, particularly in the setting of acute myocardial infarction. As these devices have become more widely used, their less visible downside has also come increasingly into view: not only the expected complications, but also technical issues that are harder to detect and may quietly impair clinical performance.

Among them, intraventricular pump orientation deserves far more attention than it usually receives. It is not enough for the device to simply be “in place” and for the console to show no warning signs. If the inlet is not properly aligned with the long axis of the left ventricle, the interaction between the pump and the blood flow changes, unloading may be compromised, and the consequence may be paid in adverse events. The study under discussion focuses precisely on that point, not particularly striking at first glance, but far from secondary: malrotation.

The authors conducted a single-center retrospective study at Hospital Gregorio Marañón including patients with cardiogenic shock treated with Impella devices (CP, 5.0, and 5.5) between 2017 and 2024. Malrotation was defined using strict echocardiographic criteria: an apparently appropriate depth in relation to the aortic annulus (3.5-5 cm), but with the inlet directed toward the mitral valve or the inferolateral wall of the left ventricle despite normal console signals.

Of 119 implanted devices, after exclusion of cases treated for other indications or lacking assessable imaging, 63 patients were analyzed. Malrotation was identified in 47.6% of cases. Interobserver agreement was excellent (kappa = 0.83).

Patients with malrotation had a higher incidence of major hemorrhage (30% vs 6%; p = .01). Hemolysis was also more frequent, although without reaching statistical significance. No significant differences were found in 30-day survival (70% vs 81.8%). Malrotation was more common in men and in patients whose shock was caused by acute myocardial infarction.

The authors’ interpretation is straightforward: malrotation of microaxial flow pumps is not an uncommon oddity, but a frequent complication, and its association with more hemorrhagic events means that both implantation technique and initial position verification should be taken more seriously.

COMMENTARY:

There is one finding in this study that should not be brushed aside too quickly: nearly one in every two devices met criteria for malrotation. This does not look like a minor finding or a mere echocardiographic curiosity. Rather, it exposes a weakness in real-world practice: we may be accepting as adequate a position that was only apparently acceptable. The fact that the figure is clearly higher than that reported in previous series suggests 2 possibilities, and both are likely true to some extent: either we are underdiagnosing this problem in routine care, or its detection depends heavily on how rigorously, or how casually, device position is reviewed.

The clinically most relevant finding is the higher rate of major hemorrhage. An absolute increase of 24% in a cohort like this is not trivial, especially in patients with so little physiological reserve. The mechanism proposed by the authors is consistent with what is already known from other forms of mechanical support: increased shear stress at the blood-inlet interface, von Willebrand factor disruption, and platelet dysfunction. Put simply, this is not just an imaging imperfection, but a technical problem with clinical consequences.

The absence of differences in 30-day survival does not weaken the observation, but it does call for a more nuanced interpretation. Malrotation may increase complications without being enough to shift mortality in patients already presenting with advanced shock. Or, more simply, a cohort of 63 patients may not have sufficient statistical power to detect such a difference. In a study like this, lack of significance should not be mistaken for lack of effect.

The predominance in men and the trend toward greater body size leave a reasonable hypothesis on the table: anatomy matters, perhaps more than we usually admit when implantation takes place in the middle of a demanding acute setting. The length of the intravascular course may influence the final orientation of the device. This is not an overinterpretation, but a plausible explanation that opens the door to incorporating individual anatomic variables into implantation planning.

It is also noteworthy that malrotation was more frequent in patients with acute myocardial infarction. This does not seem to be explained by greater baseline severity. It gives the impression that procedural context may carry more weight here: urgent implants, sometimes performed off-hours, with less room to refine projections, fewer opportunities to coordinate resources, and at times less immediate echocardiographic support. That procedural groundwork, so often treated as secondary, ultimately becomes part of the technique itself.

Another useful aspect of the study concerns diagnosis. The so-called “crushed pigtail sign” is mentioned as a specific radiologic marker, but in this series it did not discriminate between groups. That reinforces what is fairly evident in practice: echocardiography remains the central tool for truly assessing the initial position of the device. And there is a clear practical consequence: postimplant evaluation should not be limited to checking insertion depth and console parameters; it should include a systematic echocardiographic assessment of orientation.

Because that is, in the end, the study’s most important message. It is not enough to confirm that the Impella sits 3.5-5 cm below the aortic annulus. It is also not enough for the console to display normal signals. What matters is where the inlet is pointing. It should be coaxial with the long axis of the left ventricle and directed toward the apex. If it points toward the mitral valve or the inferolateral wall, the position is not satisfactory, even if the distance appears correct. On paper, that distinction may seem subtle. In practice, it is anything but.

The study rightly emphasizes the importance of initial positioning, but it also leaves an important gap: it does not provide a clear strategy for correcting malrotation once identified. And that is one of the real practical obstacles. Once the device is in place and the patient depends on it, reorienting it is not always simple or harmless. It often requires partial withdrawal, repositioning under echocardiographic guidance, or even system exchange. That difficulty reinforces a very simple idea: meticulous placement at the outset is far preferable to relying on a technically demanding correction afterward.

The study limitations are evident, and the authors do not hide them: retrospective design, single-center experience, small sample size, and exclusion of a substantial number of cases because interpretable imaging was unavailable. All of this limits generalizability. In addition, some dynamic hemodynamic variables are notably absent and would have enriched the interpretation considerably: the true degree of ventricular unloading, lactate trajectory, changes in filling pressures, or the clinical response after correction of orientation, if correction was performed. Without that information, we know that malrotation is associated with more bleeding, but we understand less clearly how much hemodynamic burden it actually adds.

Even so, the study leaves a useful lesson for everyday practice: an Impella may look well positioned and still not be. In an environment where every complication matters and every margin is narrow, systematic review of device orientation in the parasternal long-axis and apical views does not seem excessive, but rather a basic precaution.

Does this study change the indication for support? Probably not. Does it change the level of technical discipline with which the device should be implanted and checked? I would say yes. It does not prove that correcting malrotation reduces events, but it does identify a potentially modifiable variable, clinically plausible and too frequent to be dismissed as anecdotal.

Ultimately, more than an echocardiographic curiosity, Impella malrotation may be a frequent, underrecognized complication with real consequences. And if it is indeed modifiable, then we are not dealing with a minor technical detail, but with one of those small decisions that, in cardiogenic shock, can tilt the balance.